Latest database descriptions

The primary objective is to demonstrate the reliability and safety of outpatient management among patients highly suspected or confirmed as infected with COVID-19, attending an emergency department and with a revised HOME-CoV score less than 2 (negative rule).

The secondary objectives are as follows:
i. Evaluate the rate of patients having required hospitalisation within 7 days following inclusion according to the revised positive or negative HOME-CoV rule.
ii. Evaluate the rate of patients having required hospitalisation and initiation of oxygen therapy within 7 days following inclusion according to the revised positive or negative HOME-CoV rule.
iii. Evaluate the rate of patients having required intubation within 7 days following inclusion according to the revised positive or negative HOME-CoV rule.
iv. Evaluate the rate of all-cause deaths within 7 days following inclusion according to the revised positive or negative HOME-CoV rule.
v. Evaluate the performance of the revised HOME-CoV score in predicting a
negative outcome in the patient subgroup with SARS-CoV-2 infection
confirmed by RT-PCR to rule out the risk of a negative outcome when assessed as low risk.
vi. Compare the performance of the revised HOME-CoV score with that of other existing scores.

Compare the rate of patients forgoing care during the lockdown period in France, in emergency facilities at Angers and Le Mans hospitals, with that observed during a previous study in 2017.

In this situation in which data are crucial to understanding the effects of SARS-CoV-2 in the pregnant female population, our primary objective is to collect clinical and paraclinical data from a large sample of women recruited from our level 3 maternity unit, and to create biological and tissue collections with a view to responding to a series of questions, partly explained in the research programme, but which may also evolve as knowledge progresses.

Estimate the frequency of patients, with chronic inflammatory disorders, followed up as part of the FHU IMMINeNT project (gastroenterology, rheumatology, dermatology, pulmonology, neurology, internal medicine), whose follow-up has been affected by the lockdown and easing of restrictions.